February 25, 2022
A federal judge in New Jersey has ruled that claims in two Horizon Pharma patents that cover the arthritis drug Vimovo never should have been issued in the first place, sinking an infringement suit against Dr. Reddy's Laboratories that had been rattling around for half a decade.
November 08, 2019
A New Jersey federal judge refused Dr. Reddy's Laboratories Inc.'s bid to invalidate two of Horizon Pharma Inc.'s patents for arthritis drug Vimovo, ruling Thursday that the generic-drug maker hasn't shown the patents lack an adequate written description.
November 20, 2018
A New Jersey federal judge on Monday invalidated patents covering Horizon Pharma Inc.'s arthritis drug Vimovo in its suit against Dr. Reddy's Laboratories Inc. and Mylan Pharmaceuticals Inc. over their plans to manufacture and market generic versions, finding a claim term in the patents to be indefinite.